Clinical trials
Phase 3 Influenza, Human trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2008 | 1 |
| 2009 | 4 |
| 2011 | 1 |
| 2012 | 3 |
| 2016 | 2 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 5 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| Institute of Medical Biology, Chinese Academy of Medical Sciences | 3 |
| Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 3 |
| Capital Medical University | 2 |
| Hualan Biological Engineering, Inc. | 2 |
| Jiangsu Province Centers for Disease Control and Prevention | 2 |
| Sinovac Biotech Co., Ltd | 2 |
| Ab&B Bio-tech Co., Ltd.JS | 1 |
| AstraZeneca | 1 |
| Centers for Disease Control and Prevention, China | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Influenza, Human | 31 |
| Respiratory Tract Infections | 2 |
| Virus Diseases | 2 |
| COVID-19 | 1 |
| Coronavirus Infections | 1 |
| Infections | 1 |
| Lung Diseases | 1 |
| Meningitis | 1 |
| Orthomyxoviridae Infections | 1 |
| Respiratory Distress Syndrome | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.